跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PERI-COLACE CAPSULES - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PERI-COLACE CAPSULES
Authorized
STANDARD
PERI-COLACE CAPSULES
Wellspring Pharmaceutical Canada Corp
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8b59405d418adda2
Company
Wellspring Pharmaceutical Canada Corp
Type
Standard
Approval Details
Approval Id
8b59405d418adda2
Drug Approval Canada Name
PERI-COLACE CAPSULES
Product Name
PERI-COLACE CAPSULES
Status
Cancelled Post Market
Status Date
2004-07-19
Original Market Date
1998-06-30
Din
02119234
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
56:12.00
Atc Original
A06AB57 CASCARA, COMBINATIONS
Atc Name
a 06 ab 57
Aig Number
0204359001
Company Name
Wellspring Pharmaceutical Canada Corp
Company Address
600, 1741 Lower Water St, Halifax, Nova Scotia, Canada, B3J 0J2
Company Detail Path
/organization/wellspring-pharmaceutical-canada-corp
Company Information
Pharmaceutical Company Name
Wellspring Pharmaceutical Canada Corp
Country Name
Canada
Province Name
Ontario
City Name
oakville,ontario,country_ca
Address
400 Iroquois Shore Rd
Active Ingredients
DOCUSATE SODIUM
100 MG
CASANTHRANOL
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8b59405d418adda2
Type
Standard
Back to Health Canada Approvals